Skip to main content

Invega Hafyera News

Long-Acting Injected Antipsychotics Help People With Schizophrenia Stay Out of Hospital

WEDNESDAY, Jan. 31, 2024 – For people with schizophrenia hospitalized after a psychotic episode, getting a long-acting antipsychotic injection works far better than pills to keep them from returning...

FDA Approves Invega Hafyera (paliperidone palmitate) for Twice-Yearly Treatment for Adults with Schizophrenia

TITUSVILLE, N.J., Sept. 1, 2021 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced the U.S. Food and Drug Administration (FDA) has approved long-acting atypical antipsychotic ...

Ask a question

To post your own question to this support group, sign in or create an account.

Further information

Related condition support groups

Schizophrenia

Invega Hafyera patient information at Drugs.com